|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.220 USD | -6.33% |
|
-4.72% | +36.20% |
| 07-08 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 07-08 | Ovid Therapeutics Inc. Announces Executive Changes, Effective July 6, 2026 | CI |
| Market Cap | 414M 360M 335M 308M 581M 39.55B 590M 3.95B 1.55B 19.69B 1.56B 1.52B 66.03B | P/E 2026 * |
-4.6x | P/E 2027 * | -4.16x |
|---|---|---|---|---|---|
| Enterprise Value | 414M 360M 335M 308M 581M 39.55B 590M 3.95B 1.55B 19.69B 1.56B 1.52B 66.03B | EV / Sales 2026 * |
3,854x | EV / Sales 2027 * | 2,486x |
| Free-Float |
92.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | -6.33% | ||
| 1 week | -4.72% | ||
| 1 month | -17.16% | ||
| 3 months | -20.43% | ||
| 6 months | +42.31% | ||
| Current year | +36.20% |
| 1 week | 2.2 |  | 2.48 |
| 1 month | 2.2 | | 2.82 |
| Current year | 1.36 | | 3.1 |
| 1 year | 0.48 | | 3.1 |
| 3 years | 0.24 | | 4.14 |
| 5 years | 0.24 | | 4.2 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 01/01/2026 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 06/07/2026 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 01/04/2014 |
Bart Friedman
BRD | Director/Board Member | 81 | 23/11/2015 |
Barbara Duncan
BRD | Director/Board Member | 61 | 14/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 06/07/26 | Other | Chief Financial Officer | 450,625 | 0.2414% | ||
| 07/04/26 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.33% | -4.72% | +344.00% | -37.73% | 414M | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -0.75% | -3.89% | +66.68% | +135.56% | 23.43B | |
| Weighted average by Cap. | +0.22% | -2.96% | +31.35% | +116.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108K 93.45K 86.98K 79.86K 151K 10.26M 153K 1.03M 402K 5.11M 404K 395K 17.13M | 167K 145K 135K 124K 234K 15.91M 237K 1.59M 624K 7.92M 626K 612K 26.56M |
| Net income | -77.12M -67.04M -62.4M -57.29M -108M -7.36B -110M -736M -289M -3.67B -290M -283M -12.29B | -89.84M -78.1M -72.69M -66.74M -126M -8.58B -128M -857M -336M -4.27B -337M -330M -14.32B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $2.220 | -6.33% | 1,745,353 |
| 30/07/26 | $2.370 | +3.49% | 1,286,380 |
| 29/07/26 | $2.290 | -2.97% | 648,338 |
| 28/07/26 | $2.360 | +0.43% | 1,351,124 |
| 27/07/26 | $2.350 | +0.86% | 1,048,327 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
